Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inovio Pharma
(NQ:
INO
)
7.220
-0.100 (-1.37%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inovio Pharma
< Previous
1
2
3
4
5
6
7
8
9
Next >
Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript
August 10, 2021
INO earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Inovio Pharmaceuticals Q2 Earnings
August 09, 2021
Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year...
Via
Benzinga
Why Inovio Stock Is Jumping Today
August 09, 2021
Chinese regulators approved the initiation of two new clinical studies featuring Inovio's COVID-19 vaccine candidate, INO-4800.
Via
The Motley Fool
Exposures
COVID-19
Analyzing Inovio Pharmaceuticals's Unusual Options Activity
August 09, 2021
Inovio Pharmaceuticals (NASDAQ:INO) shares experienced unus...
Via
Benzinga
What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock?
August 05, 2021
Its vaccine candidate might be too far behind to matter.
Via
The Motley Fool
Exposures
COVID-19
Is Inovio Pharmaceuticals Primed For a Comeback?
July 22, 2021
The past 12 months have been tough on the vaccine maker.
Via
The Motley Fool
Exposures
COVID-19
Earnings Scheduled For August 9, 2021
August 09, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Here's Why Inovio Pharmaceuticals Soared 23% In June
July 08, 2021
Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech.
Via
The Motley Fool
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE:
Via
Benzinga
Inovio Pharmaceuticals: Return On Capital Employed Insights
June 24, 2021
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio...
Via
Benzinga
Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships
June 21, 2021
Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest.
Via
InvestorPlace
Exposures
COVID-19
Should You Buy Biotech ETFs Now?
June 16, 2021
Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and...
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
June 10, 2021
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares...
Via
Benzinga
Why Inovio Stock Is Sinking Today
June 10, 2021
Investors appear to be taking some profits after yesterday's huge gain.
Via
The Motley Fool
Exposures
COVID-19
Twitter And Regeneron Lead The SPY In Another Mixed Day Of Trading
June 09, 2021
U.S. indices at a mixed day of trading Wednesday as investors and traders weighed the U.S. 30-Year Treasury note falling to 2.1483%,...
Via
Benzinga
62 Biggest Movers From Yesterday
June 10, 2021
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID...
Via
Benzinga
Why Inovio Stock Looks Ready To Break Out, Make Bullish Reversal
June 09, 2021
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares were trading higher Wednesday as retail traders continue to push high short interest stocks higher. The stock saw above average...
Via
Benzinga
INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today
June 09, 2021
Today, INO stock is soaring amid a recently announced expanded partnership for its Covid-19 vaccine and potential short squeeze implications.
Via
InvestorPlace
Exposures
COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 09, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is...
Via
Benzinga
Inovio Pharmaceuticals Insights: Return On Capital Employed
June 08, 2021
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio...
Via
Benzinga
Inovio, Advaccine to Share $100M in Cost for Late-Stage COVID-19 Vaccine Trial
June 08, 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) has expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global...
Via
Benzinga
Exposures
COVID-19
These Vaccine Latecomers Could Still Win Big. Here's How
June 07, 2021
The key is standing out from the crowd.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
48 Stocks Moving In Wednesday's Mid-Day Session
June 09, 2021
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An...
Via
Benzinga
Why Inovio Pharmaceuticals Stock Perked Up in May
June 06, 2021
The biotech's pan-COVID-19 vaccine caught the eye of investors last month.
Via
The Motley Fool
Exposures
COVID-19
I Would Hope Inovio Isn’t Attracting ANY Serious Money
June 03, 2021
It seems as though INO stock will have a tough time getting and staying in double digits
Via
InvestorPlace
Is It Too Late to Buy Inovio Pharmaceuticals Stock?
June 03, 2021
This troubled coronavirus vaccine developer has created far more woes than joys for investors.
Via
The Motley Fool
Exposures
COVID-19
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
June 02, 2021
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more...
Via
Talk Markets
Ocugen vs. Inovio: Where Is the Smart Money Going?
May 23, 2021
They're both seeking share in the vaccine market.
Via
The Motley Fool
Exposures
COVID-19
Inovio's Latest COVID Vaccine Results: Too Little, Too Late?
May 21, 2021
Maybe not -- especially outside of the U.S.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.